Glycemic Response to Wild Rice and Wild Rice Blends in Humans Study

NCT05976633 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-10-15

No results posted yet for this study

Summary

The goal of this clinical trial is to test the effects of wild rice and wild rice blends compared to other rice on glycemic control and evaluating factors that influence glycemic response to wild rice in healthy individuals. The main questions aim to answer:

1. Is there an effect of wild rice on blends on glycemic control and response?
2. Does cooking wild rice via stovetop or microwave change its glycemic response?
3. Is the wild rice blend product palatable?
4. What is the subjective appetite when consuming the treatment?

Participants will:

* consent to attend 5 study visits being 2.5 hours each
* come to each visit fasted for at least 10-12 hours.
* complete a Motivation to Eat VAS following each blood measure

Conditions

  • Blood Glucose

Interventions

OTHER

Whole white rice (control)

One serving size (140g cooked on stovetop) of whole white rice will be provided. Cooking time will be consistently maintained throughout.

OTHER

Whole brown rice

One serving size (140g cooked on stovetop) of whole brown rice will be provided. Cooking time will be consistently maintained throughout.

OTHER

Whole wild rice

One serving size (140g cooked on stovetop) of whole wild rice will be provided. Cooking time will be consistently maintained throughout.

OTHER

15% Wild rice and 85% Brown rice blend - Stovetop

One serving size (140g cooked on stovetop) of 15% wild rice and 85% brown rice blend (Myera) will be provided. Cooking time will be consistently maintained throughout.

OTHER

15% Wild rice and 85% Brown rice blend - Microwaved

One serving size (140g cooked in microwave) of 15% wild rice and 85% brown rice blend (Myera) will be provided. Cooking time will be consistently maintained throughout.

Sponsors & Collaborators

  • Mitacs

    collaborator INDUSTRY
  • University of Manitoba

    lead OTHER

Principal Investigators

  • Dylan MacKay, PHD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-14
Primary Completion
2024-02-29
Completion
2024-02-29

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05976633 on ClinicalTrials.gov